Dutch biotech firm opening first US lab in Keene in two weeks

Dec. 1—A Dutch life-science firm plans to launch its first U.S. lab at Keene State College in two weeks, and it envisions the Elm City as a base to cultivate biotech research in the region.

Detact Diagnostics, which focuses on preventing bacterial contamination in medical settings, is scheduled to activate its lab Dec. 15 after finalizing an agreement with Keene State on Nov. 2, according to representatives of both parties. The firm announced plans in May to establish its U.S. headquarters in Keene.

Detact CEO Dr. Joost Gazendam said he founded the company based on his work as a trauma surgeon out of a need to distinguish inflammation, the natural reaction of the body's immune system to an irritant, and infection, which involves the presence of bacteria.

"There was really no good, easy, quick test to show whether or not you are infected or just inflamed, so I came up with the platform technology myself with a team and we developed that ...," Gazendam said in a video call with The Sentinel on Wednesday. "The main purpose is to detect bacteria and viruses in both a health care setting as well as in food markets."

Gazendam said Detact's plans to launch a lab in the U.S. came out of the pandemic, when the firm was developing its own COVID-19 test that used saliva rather than nose swabbing like common clinical and at-home tests. However, when Detact attempted clinical studies with its COVID test, Gazendam said the company couldn't create enough samples to receive FDA approval.

"A disadvantage for us is that we were a smaller company and the large companies in the diagnostic market kind of swallowed up that whole [COVID testing] market," he said, adding that this experience pushed Detact to seek its own American lab.

The firm also hopes to receive FDA approval for its product RenoTact, which is meant to detect peritonitis. This condition is a complication of peritoneal dialysis involving inflammation of the lining surrounding abdominal organs, according to the nonprofit National Kidney Foundation.

To apply for approval, Gazendam said Detact is required either to conduct its own clinical trials in the U.S. or outsource samples acquired in the states. In searching for a location to perform trials in America, the Netherlands-based company discovered the Elm City through its employee Julie Garcia, who is a Keene State alumna.

"Keene is looking for biotech and we're looking for a place to land in the U.S., ..." he said. "... The other thing is, in Keene, you're not one out of 1,000, so when we need help, we can knock on the door of your mayor or anybody else in the [city] council. Since we're a smaller company, we really appreciate that personal connection."

Detact signed a two-year rental contract with Keene State to run its lab on the second and third floors of the Putnam Science Center, according to James Kraly, associate deanof faculty at the college. Kraly said in an email that Detact leasing the space for $1,500 per month the first year of operation and $2,000 a month the second year.

Richard Harden, Detact's operations manager, said the firm plans to involve KSC students and faculty in lab work, similar to the company's partnerships with universities in the Dutch city of Groningen, where the firm is headquartered.

"Talks [with college faculty] have been encouraging so far, especially with the microbiology department," Harden said in an email. "... In our lab in the Netherlands we regularly have interns cycle through the lab and office. We very much hope we can replicate this with students from KSC."

Harden added that Detact plans to work with Cheshire Medical Center, which will assist in processing and handling lab samples.

Kraly said he'd like students in the college's biology, chemistry, public health and nursing programs take part in lab functions, but added that federal safety certification is priority for the first year.

While the lab will be operational mid-December and Detact can use the space for some research and development, it must be CLIA-certified for clinical trials. This means the firm will have to receive certification by the Centers for Disease Control and Prevention ensuring the lab complies with the CDC and FDA's Clinical Laboratory Improvement Amendments, which mandate standards for facilities that diagnose, prevent or treat disease.

"We intend to expand the lab in Keene quite rapidly," Gazendam said. "... We [will] put in the paperwork probably by the end of February or beginning of March, and then [inspectors] need to come and visit and do the certification."

Detact has about 10 employees, Gazendam said, and has hired two area residents to work in the Keene lab in its first few months. He and Harden said employees based in Detact's European offices in the Netherlands and the United Kingdom will make quarterly visits to Keene for operational support. The biotech firm also signed a contract with the Hannah Grimes Center for Entrepreneurship to open an office in the center which opened in July, according to Hannah Grimes Executive Director Mary Ann Kristiansen.

Gazendam said funding for the project comes from within the firm as well as a Keene financier, whom he said wished to remain anonymous. Detact previously had planned to have area financial institutions bankroll the initiative and sought to raise $1 million in startup capital, but this proved "a little trickier" than the firm expected, he said.

Kraly said the new lab isn't Keene State's first foray into biotech partnerships, having participated in state programs that support biomaterials and biomedical fields, but he noted it's the first instance of Keene State leasing a lab space.

"The partnership is the right size and scope for KSC," Kraly said. "Available space will allow Detact to establish the CLIA lab, and ... [t]he revenue from the leased space will be used to support undergraduate research in the sciences through the support of instrumentation and equipment for academic instruction."

Trisha Nail can be reached at 352-1234, extension 1436, or tnail@keenesentinel.com. Follow her on Twitter @byTrishaNail.